Sugi Predict

Sugi Predict / Compounds / SCHEMBL986701

SCHEMBL986701

SCHEMBL986701

O=C1CC(N2C(=O)c3ccccc3C2=O)C(=O)O1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 5/20 0.46
▸ CRBN Q96SW2 5/20 0.46
▸ TSHR P16473 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ IKZF3 Q9UKT9 2/20 0.46
▸ CHRM2 P08172 1/20 0.46
▸ OPRM1 P35372 1/20 0.46
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ ALOX15 P16050 2/20 0.35
▸ TNF P01375 1/20 0.35
▸ IL1B P01584 1/20 0.35
▸ TBXA2R P21731 1/20 0.35
▸ IKZF1 Q13422 1/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11606116 1.00 DDB1 (0.46) DDB1CRBNTSHRALDH1A1CYP1A2
SCHEMBL410700 0.83 CRBN (0.55) DDB1CRBNTSHRALDH1A1CYP1A2
SCHEMBL7284377 0.83 CRBN (0.55) DDB1CRBNTSHRALDH1A1CYP1A2
SCHEMBL442296 0.83 CRBN (0.55) DDB1CRBNTSHRALDH1A1CYP1A2
SCHEMBL410243 0.83 CRBN (0.55) DDB1CRBNTSHRALDH1A1CYP1A2
SCHEMBL410251 0.80 DDB1 (0.42) DDB1CRBNTSHRALDH1A1CYP1A2
SCHEMBL411989 0.80 DDB1 (0.42) DDB1CRBNTSHRALDH1A1CYP1A2
SCHEMBL12898728 0.78 TSHR (0.41) DDB1CRBNTSHRALDH1A1CYP1A2
SCHEMBL9624719 0.75 TSHR (0.59) DDB1CRBNTSHRALDH1A1CYP1A2
SCHEMBL10427066 0.69 ACHE (0.52) DDB1CRBNTSHRALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115928239-B Preparation method of polypropylene fiber with low auxiliary agent mobility 广东蒙泰高新纤维股份有限公司 2025-03-25 — — CN disclosed
CN-115928239-A Preparation method of polypropylene fiber with low auxiliary agent mobility 广东蒙泰高新纤维股份有限公司 2023-04-07 — — CN disclosed
CN-108475822-B Nonaqueous electrolyte solution for secondary battery and secondary battery provided with same 斯泰拉化工公司 2022-03-11 — — CN disclosed
US-20140023592-A1 SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS RWTH AACHEN (DE) 2014-01-23 — — US disclosed
EP-2587263-A1 Self coupling recombinant antibody fusion proteins Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2013-05-01 — — EP disclosed
US-20110014196-A1 Drug Transfer into Living Cells COVALYS BIOSCIENCES AG (CH) 2011-01-20 — — US disclosed
CN-101828113-A Self-binding recombinant antibody fusion proteins FRAUNHOFER GES FORSCHUNG 2010-09-08 — — CN disclosed
US-20100183516-A1 SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2010-07-22 — — US disclosed
EP-2171456-A2 SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2010-04-07 — — EP disclosed
WO-2009043899-A1 DRUG TRANSFER INTO LIVING CELLS COVALYS BIOSCIENCES AG (CH) 2009-04-09 — — WO disclosed
WO-2009013359-A2 SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS FRAUNHOFER GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E. V. (DE) 2009-01-29 — — WO disclosed
EP-1051655-B1 METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY ISTA PHARMACEUTICALS INC (US) 2005-09-28 — — EP disclosed
EP-1051655-A4 METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY ISTA PHARMACEUTICALS INC (US) 2003-03-19 — — EP disclosed
US-6161544-A Methods for accelerated orthokeratology KERATOFORM, INC. (US) 2000-12-19 — — US disclosed
EP-1051655-A1 METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY Ista Pharmaceuticals, Inc. (US) 2000-11-15 — — EP disclosed
WO-1999039238-A1 METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY KERATOFORM, INC. (US) 1999-08-05 — — WO disclosed
EP-0325288-B1 IMIDO-AROMATIC PERCARBOXYLIC ACIDS AUSIMONT S.p.A. (IT) 1993-09-01 — — EP disclosed
EP-0325289-B1 BLEACHING AGENTS COMPRISING IMIDO-AROMATIC PERCARBOXYLIC ACIDS AUSIMONT S.p.A. (IT) 1993-09-01 — — EP disclosed
EP-0325289-A1 Bleaching agents comprising imido-aromatic percarboxylic acids AUSIMONT S.p.A. (IT) 1989-07-26 — — EP disclosed
EP-0325288-A1 Imido-aromatic percarboxylic acids AUSIMONT S.p.A. (IT) 1989-07-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110014196-A1 Drug Transfer into Living Cells TSPO, MPI, ABCB1 DDB1 848/4885CRBN 2019/4885TSHR 1933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.